Navigation Links
Dr. Dennis Fenton and Dr. Steve Kaldor Join Amira Board of Directors
Date:3/31/2008

SAN DIEGO, March 31 /PRNewswire/ -- Amira Pharmaceuticals, a small molecule pharmaceutical company focused on the discovery and development of compounds to treat inflammatory disease, today announced the appointment of two additional members to its board of directors: Dennis M. Fenton, Ph.D. and Stephen W. Kaldor, Ph.D.

Dr. Fenton has 30 years of pharmaceutical and biotechnology experience, including over two decades at Amgen where he played an instrumental role in the development of the company into a global, fully-integrated, multi-billion dollar organization. Fenton's broad background includes executive leadership roles in manufacturing, process development, sales and marketing, operations and quality control. His most recent role at Amgen was as Executive Vice President of Operations.

Fenton holds a B.S. in Biology from Manhattan College and a Ph.D. in Microbiology from Rutgers University.

"Dennis is a biotechnology pioneer," said chief executive officer, Bob Baltera. "His experience and insight from his years at Amgen will be extremely useful for Amira as we plan our future. In addition to Dennis, we are also very pleased that Steve Kaldor will join our board of directors. Steve's experience in successful start-up companies further deepens our pool of experience and knowledge and I'm sure he will serve as a great partner for us."

Dr. Kaldor is currently president and chief executive officer of Ambrx, a private biotechnology company focused on the development of next-generation, protein-based medicines. Prior to joining Ambrx, Kaldor served as president and chief scientific officer of Syrrx, a structure-based drug discovery company, which he led through its $270 million acquisition by Takeda in 2005. He also spent over twelve years in various research and development roles at Eli Lilly and is a co-inventor of Viracept(R), a marketed AIDS drug.

Kaldor holds a B.S. in Chemistry from Columbia University and a Ph.D. in Organ
'/>"/>

SOURCE Amira Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Dennis Joyce Joins Executive and Board Search Firm Hodge / Niederer / Cariani / Lindsay
2. Bacchus Vascular Names Dennis Rosenberg as Vice President of Marketing
3. Kendle Executive Dennis Hurley, DrSc to Present Keynote Address at DIA Latin American Congress 2007
4. TIGroup Names Dennis M. Smith as Chief Financial Officer
5. Dr. Steve Liu, CEO of Ingenious Med, Joins Benchmarks Committee at SHM
6. Stevens chemists identify compounds to lure nutria, a rat-like pest ravaging Gulf Coast wetlands
7. Northwestern Memorial Hospitals Steven J. Stryker MD Unveils Campaign With Empower Public Relations
8. Stevens UV expert at Science-on-Saturday program
9. Statement of Steve Pasierb, President and CEO, Partnership for a Drug-Free America on New SAMHSA Study On Cough Medicine Abuse
10. Statement of Steve Pasierb, President and CEO, Partnership for a Drug-Free America on the Release of the 2007 Monitoring the Future Study
11. Play by Steve Nash, Assisted by Milk
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... Biostimulants are widely applied in turf ... ornamentals. These also help turf and ornamentals in absorption ... Turf, ornamentals, and flowers appear healthy and strong as ... increased from the last few years. The most dominating ... Europe, with around 40% share in 2013, and is ...
(Date:7/11/2014)... Researchers from The Miriam Hospital have found that ... significantly higher rates of smoking than those without ... less likely to attempt quitting than those without ... be sufficient for this population. The study and ... print in the American Journal of Public ...
(Date:7/11/2014)... 2014 The Corn Farming ... 2014 on the heels of fresh biofuel demand. The ... dedicate a larger share of their farmland to cultivating ... regulations required the mixing of 5.0% renewable content in ... the United States created a key export market for ...
(Date:7/11/2014)... FRIDAY, July 11, 2014 (HealthDay News) -- Prostate cancer ... disease, receive less effective treatment and die sooner if ... Researchers analyzed data from more than 41,200 American men ... and 2007. They followed them through 2009. Nearly 1,900 ... the two years before their prostate cancer was discovered. ...
(Date:7/11/2014)... 11, 2014 Riverside Health System became the ... in Virginia in late 2012 and now, in partnership with ... residents throughout the Williamsburg and Newport News region. , Also ... and benefits to independent older adults who wish to remain ... safety net of continuing care services as well as control ...
Breaking Medicine News(10 mins):Health News:Biostimulants Market in Turf and Ornamentals is Expected to Reach $ 3.8 Billion by 2018 - New Report by MicroMarket Monitor 2Health News:Biostimulants Market in Turf and Ornamentals is Expected to Reach $ 3.8 Billion by 2018 - New Report by MicroMarket Monitor 3Health News:Miriam Hospital study examines smoking prevalence 2Health News:Corn Farming in Canada Industry Market Research Report Now Available From IBISWorld 2Health News:Corn Farming in Canada Industry Market Research Report Now Available From IBISWorld 3Health News:Depression May Make It Harder to Beat Prostate Cancer 2Health News:Riverside and Williamsburg Landing Partner to Offer First of Its Kind Service to Virginians Who Want to Age in Place 2Health News:Riverside and Williamsburg Landing Partner to Offer First of Its Kind Service to Virginians Who Want to Age in Place 3Health News:Riverside and Williamsburg Landing Partner to Offer First of Its Kind Service to Virginians Who Want to Age in Place 4
... in Care, The experience of Ontario, Canada ... inequities but not education-related disparities in health care ... data on more than 25,558 residents of Ontario, ... covered by government, researchers find patient income levels ...
... related to heart disease, study shows , MONDAY, Sept. 21 ... at higher risk for having a heart attack, especially those ... both seasonal and the pandemic H1N1 swine flu are circulating ... are urged to get a seasonal flu shot and an ...
... of a specific gene variant shows a strong ... (UC) have demonstrated. In addition, the research indicates ... individuals harboring the gene variant can be further ... Stambrook, PhD, a professor in the department of ...
... , , SACRAMENTO, Calif., ... the Twin Rivers Unified School District will be able to ... created jointly by the California Dental Association Foundation, University of ... California HealthCare Foundation with start-up funding from Verizon. , ...
... 21 HTH Worldwide, a global health and safety ... are now available with sickness, accident and medical evacuation ... that include direct payment to participating doctors and hospitals ... the market today limit medical benefits to $25,000 or ...
... MARINA DEL REY, Calif., Sept. 21 Electronic medical records have ... Dr. Richard Merkin, CEO for Heritage Provider Network. HPN and its ... York have been eliminating waste and cutting costs while providing quality ... on the importance of integrating electronic medical records. , , ...
Cached Medicine News:Health News:September/October 2009 Annals of Family Medicine tip sheet 2Health News:September/October 2009 Annals of Family Medicine tip sheet 3Health News:September/October 2009 Annals of Family Medicine tip sheet 4Health News:September/October 2009 Annals of Family Medicine tip sheet 5Health News:September/October 2009 Annals of Family Medicine tip sheet 6Health News:Flu Can Raise Chances of Heart Attack 2Health News:Flu Can Raise Chances of Heart Attack 3Health News:Cancer predisposition from genetic variation shows strong gender bias 2Health News:New Tele-Health Care Project to Provide Dental Care to Underserved Communities in California 2Health News:New Tele-Health Care Project to Provide Dental Care to Underserved Communities in California 3Health News:New Tele-Health Care Project to Provide Dental Care to Underserved Communities in California 4Health News:HTH Worldwide Introduces Trip Protection Insurance With Major Medical Benefits 2Health News:Heritage Provider Network and Dr. Richard Merkin Highlight Cutting Health Care Costs Using Electronic Medical Records 2
(Date:7/10/2014)... , July 10, 2014  BC Technical, the largest ... MiE America , Inc., a leading provider of Siemens ... a long-term agreement naming BC Technical as the authorized ... MiE and BC Technical announced today that ... establish BC Technical as the service and systems provider ...
(Date:7/10/2014)... CVS Caremark Corporation (NYSE: CVS ) today announced ... of $0.275 (27.5 cents) per share on the corporation,s common ... holders of record on July 21, 2014. About ... helping people on their path to better health as the ... . Through the company,s more than 7,600 CVS/pharmacy stores; ...
(Date:1/15/2014)... , Jan. 15, 2014  Research and Markets ( http://www.researchandmarkets.com/research/6k27gw/dental ... Consumables Market - Global Industry Analysis, Size, Share, Growth, ... their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ... are used on patients in order to treat dental ...
Breaking Medicine Technology:BC Technical Partners With MiE America To Be Authorized Provider Of Systems & Service 2Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2018 2Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2018 3
... COTTAGE, N.Y., June 30 XTL,Biopharmaceuticals Ltd. (Nasdaq: ... patient randomization into its Phase 2b study of Bicifadine,-- ... the,treatment of diabetic neuropathic pain. 350 patients were randomized ... Company expects to,have the last patient complete the study ...
... new understanding of,the role played by the protein ... novel therapies to rebuild muscle tissue,damaged by disease, ... Institute for Cancer Research and Molecular Medicine at ... The researchers reported their findings, "Cdk9-55: A ...
Cached Medicine Technology:XTL Biopharmaceuticals Announces Completion of Patient Randomization Into the Bicifadine Phase 2b Clinical Trial for the Treatment of Diabetic Neuropathic Pain 2XTL Biopharmaceuticals Announces Completion of Patient Randomization Into the Bicifadine Phase 2b Clinical Trial for the Treatment of Diabetic Neuropathic Pain 3International Team Locates Key Player in Muscle Regeneration 2
Li Brand™ Surgical Hemostat. ("dissecting clamp") For NSV and other procedures....
... for applications such as vasectomy that ... ,The autoclavable handpiece with six-foot cord ... cautery electrodes, allowing the physician to ... wide variety of procedures., ,The 2201 ...
No Scalpel Vasectomy Hemostat 5 1/2" (14cm), smooth sharp point, curved, gold finger rings...
Li Brand™ Ringed Forceps. ("fixation clamp") For NSV and other procedures. Ring diameter approximately 3.5 mm. Manufactured exclusively for AMI to exacting specifications by a German company....
Medicine Products: